A longitudinal observational study of a cohort of patients with relapsing-remitting multiple sclerosis treated with glatiramer acetate

被引：0
|
作者：
Moreau, T.
Brudon, F.
Debouverie, M.
Heinzlef, O.
Lebrun-Frenay, C.
Gury, C.
机构：
[1] CHRU Hop Gen, Dijon, France
[2] Clin Tonkin, Villeurbanne, France
[3] Hop St Julien, Nancy, France
[4] Hop Poissy St Germain en Laye, Poissy, France
[5] Hop Louis Pasteur, Nice, France
[6] Lab Sanofi Aventis, Paris, France
来源：
MULTIPLE SCLEROSIS | 2006年 / 12卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：S99 / S99
页数：1
相关论文
共 50 条
  • [1] Spotlight on glatiramer acetate in relapsing-remitting multiple sclerosis
    Simpson, D
    Noble, S
    Perry, C
    [J]. BIODRUGS, 2003, 17 (03) : 207 - 210
  • [2] Glatiramer acetate for treatment of relapsing-remitting multiple sclerosis
    Johnson, Kenneth P.
    [J]. EXPERT REVIEW OF NEUROTHERAPEUTICS, 2012, 12 (04) : 371 - 384
  • [3] Spotlight on Glatiramer Acetate in Relapsing-Remitting Multiple Sclerosis
    Dene Simpson
    Stuart Noble
    Caroline Perry
    [J]. BioDrugs, 2003, 17 : 207 - 210
  • [4] Glatiramer acetate: Promise in relapsing-remitting multiple sclerosis?
    不详
    [J]. Drugs & Therapy Perspectives, 1998, 11 (10) : 1 - 5
  • [5] Experience of Glatiramer Acetate in the Treatment of Relapsing-Remitting Multiple Sclerosis Patients
    Taskapilioglu, Ozlem
    Turan, Asli Bahar
    Albas, Murat
    Turan, Omer Faruk
    [J]. TURKISH JOURNAL OF NEUROLOGY, 2012, 18 (01) : 17 - 20
  • [6] QualiCOP: an open-label, prospective, observational study of glatiramer acetate in patients with relapsing-remitting multiple sclerosis
    Ziemssen, T.
    Calabrese, P.
    Penner, I. -K.
    Carroll, C. A.
    Apfel, R.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2014, 21 : 340 - 340
  • [7] Fatigue in relapsing-remitting multiple sclerosis patients using glatiramer acetate - FOCUS Study
    Jongen, PJH
    Carton, H
    Sanders, EACM
    Seeldrayers, P
    Fredrikson, S
    Andersson, M
    [J]. MULTIPLE SCLEROSIS, 2004, 10 (7032): : S257 - S257
  • [8] QualiCOP: an open-label, prospective, observational study of glatiramer acetate in patients with relapsing-remitting multiple sclerosis
    Ziemssen, T.
    Calabrese, P.
    Penner, I. -K.
    Carroll, C. A.
    Apfel, R.
    [J]. JOURNAL OF NEUROLOGY, 2014, 261 : S229 - S229
  • [9] A longitudinal observational study of a cohort of patients with relapsingremitting multiple sclerosis treated with glatiramer acetate
    Debouverie, M.
    Moreau, T.
    Lebrun, C.
    Heinzlef, O.
    Brudon, F.
    Msihid, J.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2007, 14 (11) : 1266 - 1274
  • [10] In vivo monitoring of neuroprotection by glatiramer acetate in patients with relapsing-remitting multiple sclerosis
    Ehling, R.
    Di Pauli, F.
    Kuenz, B.
    Millonig, A.
    Lutterotti, A.
    Gneiss, C.
    Santner, W.
    Schocke, M.
    Loescher, W.
    Deisenhammer, F.
    Reindl, M.
    Berger, T.
    [J]. JOURNAL OF NEUROLOGY, 2009, 256 : S243 - S243
12345